Promoter Hypermethylation in Plasma-Derived Cell-Free DNA as a Prognostic Marker for Pancreatic Adenocarcinoma Staging

International Journal of Cancer - United States
doi 10.1002/ijc.31024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

LRAT Promoter Hypermethylation as a Prognostic Marker for Colorectal Cancer Impairs Retinol Metabolism

Journal of Clinical Gastroenterology and Treatment
2017English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

The Prognostic Efficacy of Cell-Free DNA Hypermethylation in Colorectal Cancer

Oncotarget
Oncology
2018English

MT1G Hypermethylation: A Potential Prognostic Marker for Hepatoblastoma

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Ascites-Derived Pancreatic Ductal Adenocarcinoma Primary Cell Cultures as a Platform for Personalised Medicine

British Journal of Cancer
Cancer ResearchOncology
2014English

Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients With Brain Tumors Under Perillyl Alcohol-Based Therapy

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

TM4SF1 as a Prognostic Marker of Pancreatic Ductal Adenocarcinoma Is Involved in Migration and Invasion of Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Desmogleins as Prognostic Biomarkers in Resected Pancreatic Ductal Adenocarcinoma

British Journal of Cancer
Cancer ResearchOncology
2015English

Downregulation of ID4 by Promoter Hypermethylation in Gastric Adenocarcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy